Use of the low-molecular-weight heparin nadroparin during pregnancy. A review

Current Medical Research and Opinion

Volumn 19, Issue 1, 2003, Pages 4-12

  Makatsaria, Alexander D ^a   Bitsadze, Victoria O ^a   Dolgushina, N V ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Antiphospholipid antibodies; Heparin, low molecular weight; Nadroparin; Pregnancy; Thrombophilia

Indexed keywords

CORTICOSTEROID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; FAMILIAL DISEASE; FEMALE; FETUS WASTAGE; GENITAL HERPES; HEART VALVE PROSTHESIS; HEPARINIZATION; HERPES SIMPLEX; HIGH RISK PREGNANCY; HUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; FIBRINOLYTIC AGENTS; HEART VALVE PROSTHESIS; HERPES SIMPLEX; HUMANS; NADROPARIN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, INFECTIOUS; RUSSIA; VENOUS THROMBOSIS;

EID: 0037236071     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001371     Document Type: Review

References (29)

1. Duplaga BA, Rivers CW, Nutescu EN. Dosing and monitoring of low molecular weight heparins in special populations. Pharmacotherapy 2001;21:218-234
2. Arkel YS, Ku DH. Thrombophilia and pregnancy: review of the literature and some original data. Clin Appl Thromb Hemost 2001;7:259-268
3. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122-31S.
4. Bazzan M, Donvito V. Low molecular weight heparin during pregnancy. Thromb Res 2001;101:V175-86
5. Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonage E, et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 1999;81:668-72
6. Ensom M, Stephenson MD. Low molecular weight heparins in pregnancy. Pharmacotherapy 1999;19:1013-25
7. Boda Z, Laslzlo P, Rejto L, Tornai I, Pfliegler G, Blasko G, et al. Low molecular weight heparin as thromboprophylaxis during the whole period of pregnancy. Thromb Haemost 1996;76:124-8
8. Harenberg J, Wurzner B, Zimmerman R, Schettler G. Bioavailability and antagonisation of the low molecular weight heparin CY 216 in man. Thromb Res 1986;44:549
9. Ginsberg JS, Hirsch J. Use of antithrombotic agents during pregnancy. Chest 1998;114:524-30S
10. Sellman JS, Holman RL. Thromboembolism during pregnancy. Risks, challenges and recommendations. Postgrad Med 2000;108:71-84
11. Tam WH, Wong KS, Yuen PM, Leung TN, Li CY. Low molecular weight heparin and thromboembolism in pregnancy. Lancet 1999;353:932
12. Daskalakis G, Antsaklis A, Papageorgiou I, Michalas S. Thrombosis prophylaxis after treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 1997;74:165-7
13. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-16
14. Boda Z, Laszlo P, Pfliegler G, Tornai I, Rejto L, Schlammadinger A. Thrombophilia, anticoagulant therapy and pregnancy. Orvosi Hetilap 1998;139:3113-16
15. Genievskaya MG, Starchenko KV, Bitsadze VO, Sinha A, Makatsaria AD. Hereditary thrombophilia and fetal loss. Eur J Obstet Gynecol Reprod Biol 1999;86:S33-101 (Abstr 184)
16. Roberts N, Ross D, Flint SK, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. Br J Obstet Gynaecol 2001;108:327-9
17. Lee LH, Liauw PCY, Ng ASH. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996;76:628-30
18. Arnaout MS, Kazma H, Khalil A, Shasha N, Nasrallah A, Karam K, et al. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? Clin Exp Obstet Gynecol 1998;25:101-4
19. Bitsadze VO, Makatsaria AD. The use of low molecular weight heparin (Fraxiparine) for the prevention of thromboembolic complication in pregnant patients with heart valve prosthesis. Haemostasis 2000;30(Suppl 1):127 (Abstr)
20. Ellison J, Thomson, AJ, Walker ID, Greener IA. Use of enaxoparin in a pregnant woman with a mechanical heart valve prosthesis. Br J Obstet Gynaecol 2001;108:757-9
21. Rowan JA, McCowan LME, Raudkivi PJ, North RA. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:633-7
22. Heilmann L, Schneider DM, von Tempelhoff. Antithrombotic therapy in high-risk pregnancy. Hematol Oncol Clin North Am 2000;14:1133-50
23. Iankova Z, Bogdanova M. Successful prophylaxis in a pregnancy with thrombophilic states. [article in Bulgarian] Vutr Boles 1999;31:17-20
24. Genievskaya MG, Makatsaria AD. Low molecular weight heparin (Fraxiparine) as long-term single agent therapy in pregnant patients with antiphospholipid syndrome. Haemostasis 2000;30(Suppl 1):161 (Abstr 184)
25. Genievskaya MG, Makatsaria AD. Pregnancy management in patients with antiphospholipid antibodies without antiphospholipid syndrome. Haemostasis 2000;30(Suppl 1):161 (Abstr 185)
26. Dolgushina NV, Makatsaria AD. The use of low molecular weight heparin in pregnant patients with herpes and antiphospholipid syndrome. The Herald of Russian Association of Obstetricians and Gynecologists 2001;1:41-6
27. Verstraete M, Colin MD, Prentice RM, Samama MD, Verhaeghe MD. A European view on the North American Fifth Consensus on Antithrombotic Therapy. Chest 2000;117:1755-70
28. Conard J, Horellou MH, Samama HH. Management of pregnancy in women with thrombophilia. Haemostasis 1999;29(Suppl 1):98-104
29. Guyatt GH, Cook DJ, Sackett DL, Eckman M, Pauker S. Grades of recommendation for antithrombotic agents. Chest 1998;114:441-4S